[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100523919":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":39,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Fujian Cancer Hospital","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"cervical cancer patients with radiotherapy",null,"The overall dose should be more than 75 Gy. patients received surgery should be excluded.",[13],"Radiation: external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"RADIATION","external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)","Radical RT consisted of external pelvic beam radiotherapy (EBRT) and individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT).Cisplatin-based concurrent chemoradiotherapy (CCRT) was recommended for CC patients unless for economic status, age consideration and patients' desires.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Yang Sun, PhD","CONTACT","+8615959028989","sunyang@fjzlhospital.com",[27],{"facility":5,"status":10,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":10},"Fuzhou","Fujian","350014","China","CN",{"type":34,"coordinates":35},"Point",[36,37],119.30611,26.06139,{"lat":37,"lon":36},{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100523919","a-predictive-model-for-early-metastasis-in-cervical-cancer-patients-after-radiotherapy-100523919",false,"NCT06101966","A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy","A Novel Predictive Model and Risk Stratification for Early Metastasis in Cervical Cancer Patients After Radiotherapy","Inclusion Criteria:\n\n* patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled\n\nExclusion Criteria:\n\n* (1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials","FEMALE","20 Years","85 Years",{"count":52,"type":53},500,"ESTIMATED","OBSERVATIONAL","This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.",[57,58,59,60,61],"Cervical Cancer","Radiotherapy","Distant Metastasis","Prognostic Model","Risk Factor","NOT_YET_RECRUITING","2023-10-21",{"date":65,"type":66},"2023-10-26","ACTUAL",{"date":68,"type":53},"2023-12-01",{"date":70,"type":53},"2027-12-01",{"name":5,"class":6},1]